Copyright
©The Author(s) 2022.
World J Clin Oncol. Apr 24, 2022; 13(4): 287-302
Published online Apr 24, 2022. doi: 10.5306/wjco.v13.i4.287
Published online Apr 24, 2022. doi: 10.5306/wjco.v13.i4.287
Table 3 Maximum standardized uptake value according to anatomical region of interest and according to tumor size
| Anatomical region of interest | Tumor ≤ 20 mm | Tumor > 20 mm | P |
| n = 18 | n = 18 | ||
| Breast ipsilateral | |||
| SUVmax, mean (SD) | 2.3 (1.4) | 4.4 (3.1) | 0.012 |
| Breast contralateral | |||
| SUVmax, mean (SD) | 1.7 (1.3) | 1.7 (0.6) | 0.918 |
| Axillary ipsilateral | |||
| SUVmax, mean (SD) | 1.8 (0.9) | 2.8 (1.8) | 0.063 |
| Axillary contralateral | |||
| SUVmax, mean (SD) | 1.5 (0.5) | 1.8 (0.5) | 0.140 |
| Sternal | |||
| SUVmax, mean (SD) | 1.8 (0.5) | 2.1 (0.6) | 0.061 |
| All breast, axillary and sternal regions combined | |||
| SUVmax, mean (SD) | 2.7 (1.5) | 4.8 (3.0) | 0.014 |
- Citation: Perrin J, Farid K, Van Parijs H, Gorobets O, Vinh-Hung V, Nguyen NP, Djassemi N, De Ridder M, Everaert H. Is there utility for fluorine-18-fluorodeoxyglucose positron-emission tomography scan before surgery in breast cancer? A 15-year overall survival analysis. World J Clin Oncol 2022; 13(4): 287-302
- URL: https://www.wjgnet.com/2218-4333/full/v13/i4/287.htm
- DOI: https://dx.doi.org/10.5306/wjco.v13.i4.287